{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:29:40Z","timestamp":1789046980540,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12028-024-02183-z","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:58:48Z","timestamp":1734721128000},"page":"1-21","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Guidelines for Seizure Prophylaxis in Patients Hospitalized with Nontraumatic Intracerebral Hemorrhage: A Clinical Practice Guideline for Health Care Professionals from the Neurocritical Care Society"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0719-2522","authenticated-orcid":false,"given":"Jennifer A.","family":"Frontera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appaji","family":"Rayi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eljim","family":"Tesoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J.","family":"Gilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DaiWai","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie S.","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"issue":"9","key":"2183_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1474-4422(22)00235-6","volume":"21","author":"L Peter-Derex","year":"2022","unstructured":"Peter-Derex L, Philippeau F, Garnier P, Andr\u00e9-Obadia N, Boulogne S, Catenoix H, et al. Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2022;21(9):781\u201391.","journal-title":"Lancet Neurol"},{"issue":"9","key":"2183_CR2","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/01.WNL.0000063316.47591.B4","volume":"60","author":"PM Vespa","year":"2003","unstructured":"Vespa PM, O\u2019Phelan K, Shah M, Mirabelli J, Starkman S, Kidwell C, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60(9):1441\u20136.","journal-title":"Neurology"},{"issue":"13","key":"2183_CR3","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/01.wnl.0000281664.02615.6c","volume":"69","author":"J Claassen","year":"2007","unstructured":"Claassen J, Jett\u00e9 N, Chum F, Green R, Schmidt M, Choi H, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69(13):1356\u201365.","journal-title":"Neurology"},{"issue":"7","key":"2183_CR4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1161\/STROKEAHA.114.004686","volume":"45","author":"E Haapaniemi","year":"2014","unstructured":"Haapaniemi E, Strbian D, Rossi C, Putaala J, Sipi T, Mustanoja S, et al. The CAVE score for predicting late seizures after intracerebral hemorrhage. Stroke. 2014;45(7):1971\u20136.","journal-title":"Stroke"},{"issue":"3","key":"2183_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jcrc.2008.10.015","volume":"24","author":"MC Garrett","year":"2009","unstructured":"Garrett MC, Komotar RJ, Starke RM, Merkow MB, Otten ML, Connolly ES. Predictors of seizure onset after intracerebral hemorrhage and the role of long-term antiepileptic therapy. J Crit Care. 2009;24(3):335\u20139.","journal-title":"J Crit Care"},{"issue":"4","key":"2183_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104628","volume":"29","author":"D Pinto","year":"2020","unstructured":"Pinto D, Prabhakaran S, Tipton E, Naidech AM. Why physicians prescribe prophylactic seizure medications after intracerebral hemorrhage: an adaptive conjoint analysis. J Stroke Cerebrovasc Dis. 2020;29(4): 104628.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"9","key":"2183_CR7","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1179\/1743132813Y.0000000197","volume":"35","author":"MB Jensen","year":"2013","unstructured":"Jensen MB, Sattar A, Al SK. Survey of prophylactic antiseizure drug use for non-traumatic intracerebral hemorrhage. Neurol Res. 2013;35(9):984\u20137.","journal-title":"Neurol Res"},{"issue":"3","key":"2183_CR8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10072-021-05588-2","volume":"43","author":"MJ Gigliotti","year":"2022","unstructured":"Gigliotti MJ, Srikanth S, Cockroft KM. Patterns of prophylactic anticonvulsant use in spontaneous intracerebral and subarachnoid hemorrhage: results of a practitioner survey. Neurol Sci. 2022;43(3):1873\u20137.","journal-title":"Neurol Sci"},{"key":"2183_CR9","doi-asserted-by":"crossref","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al., American Heart Association\/American Stroke Association. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53(7):e282\u2013361.","DOI":"10.1161\/STR.0000000000000407"},{"key":"2183_CR10","unstructured":"GRADE Guidelines Workshop + focus on implementation. 2022. https:\/\/gradeconf.org\/2022-11\/."},{"key":"2183_CR11","unstructured":"Schunemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. GRADE handbook. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html."},{"key":"2183_CR12","unstructured":"GRADE. 2022. https:\/\/www.gradeworkinggroup.org\/."},{"issue":"4","key":"2183_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395\u2013400.","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"2183_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/phar.2760","volume":"43","author":"M Strein","year":"2023","unstructured":"Strein M, Holton-Burke JP, Stilianoudakis S, Moses C, Almohaish S, Brophy GM. Levetiracetam-associated behavioral adverse events in neurocritical care patients. Pharmacotherapy. 2023;43(2):122\u20138.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"2183_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604\u20137.","journal-title":"Stroke"},{"key":"2183_CR16","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane handbook for systematic reviews of interventions version 6.3. Cochrane; 2022."},{"key":"2183_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.","journal-title":"BMJ"},{"issue":"4","key":"2183_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"2183_CR19","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.1016\/j.wneu.2020.05.197","volume":"141","author":"C Christie","year":"2020","unstructured":"Christie C, Daggubati L, Patel N, Matthews N, Lehman EB, Cockroft KM. Effect of newer generation anticonvulsant prophylaxis on seizure incidence after spontaneous intracerebral hemorrhage. World Neurosurg. 2020;141:e461\u20135.","journal-title":"World Neurosurg"},{"issue":"3","key":"2183_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.eplepsyres.2011.04.002","volume":"95","author":"R Gilad","year":"2011","unstructured":"Gilad R, Boaz M, Dabby R, Sadeh M, Lampl Y. Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment? Epilepsy Res. 2011;95(3):227\u201331.","journal-title":"Epilepsy Res"},{"key":"2183_CR21","doi-asserted-by":"crossref","unstructured":"Mess\u00e9 SR, Sansing LH, Cucchiara BL, Herman ST, Lyden PD, Kasner SE; CHANT investigators. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11(1):38\u201344.","DOI":"10.1007\/s12028-009-9207-y"},{"issue":"9","key":"2183_CR22","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1097\/CCM.0000000000003272","volume":"46","author":"AM Naidech","year":"2018","unstructured":"Naidech AM, Beaumont J, Muldoon K, Liotta EM, Maas MB, Potts MB, et al. Prophylactic seizure medication and health-related quality of life after intracerebral hemorrhage. Crit Care Med. 2018;46(9):1480\u20135.","journal-title":"Crit Care Med"},{"issue":"10","key":"2183_CR23","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.clineuro.2011.07.008","volume":"113","author":"RT Reddig","year":"2011","unstructured":"Reddig RT, Nixdorf KE, Jensen MB. The prophylactic use of an antiepileptic drug in intracerebral hemorrhage. Clin Neurol Neurosurg. 2011;113(10):895\u20137.","journal-title":"Clin Neurol Neurosurg"},{"key":"2183_CR24","doi-asserted-by":"crossref","unstructured":"Zandieh A, Mess\u00e9 SR, Cucchiara B, Mullen MT, Kasner SE; VISTA-ICH Collaborators. Prophylactic use of antiepileptic drugs in patients with spontaneous intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2016;25(9):2159\u201366.","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.05.026"},{"key":"2183_CR25","doi-asserted-by":"crossref","unstructured":"Savalia K, Sekar P, Moomaw CJ, Koch S, Sheth KN, Woo D, et al.; ERICH Investigators. Effect of primary prophylactic antiseizure medication for seizure prevention following intracerebral hemorrhage in the ERICH study. J Stroke Cerebrovasc Dis. 2022;31(1):106143.","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106143"},{"issue":"4","key":"2183_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3340\/jkns.2012.52.4.312","volume":"52","author":"KM Woo","year":"2012","unstructured":"Woo KM, Yang SY, Cho KT. Seizures after spontaneous intracerebral hemorrhage. J Korean Neurosurg Soc. 2012;52(4):312\u20139.","journal-title":"J Korean Neurosurg Soc"},{"key":"2183_CR27","doi-asserted-by":"crossref","unstructured":"Sheth KN, Martini SR, Moomaw CJ, Koch S, Elkind MS, Sung G, et al.; ERICH Investigators. Prophylactic antiepileptic drug use and outcome in the ethnic\/racial variations of intracerebral hemorrhage study. Stroke. 2015;46(12):3532\u20135.","DOI":"10.1161\/STROKEAHA.115.010875"},{"issue":"3","key":"2183_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12028-012-9776-z","volume":"17","author":"TW Battey","year":"2012","unstructured":"Battey TW, Falcone GJ, Ayres AM, Schwab K, Viswanathan A, McNamara KA, et al. Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care. 2012;17(3):361\u20136.","journal-title":"Neurocrit Care"},{"issue":"2","key":"2183_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12028-017-0385-8","volume":"27","author":"J Mackey","year":"2017","unstructured":"Mackey J, Blatsioris AD, Moser EA, Carter RJ, Saha C, Stevenson A, et al. Prophylactic anticonvulsants in intracerebral hemorrhage. Neurocrit Care. 2017;27(2):220\u20138.","journal-title":"Neurocrit Care"},{"issue":"10","key":"2183_CR30","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1161\/STROKEAHA.116.012410","volume":"47","author":"EJ Gilmore","year":"2016","unstructured":"Gilmore EJ, Maciel CB, Hirsch LJ, Sheth KN. Review of the utility of prophylactic anticonvulsant use in critically ill patients with intracerebral hemorrhage. Stroke. 2016;47(10):2666\u201372.","journal-title":"Stroke"},{"issue":"11","key":"2183_CR31","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00268-016-3606-y","volume":"40","author":"B Zangbar","year":"2016","unstructured":"Zangbar B, Khalil M, Gruessner A, Joseph B, Friese R, Kulvatunyou N, et al. Levetiracetam prophylaxis for post-traumatic brain injury seizures is ineffective: a propensity score analysis. World J Surg. 2016;40(11):2667\u201372.","journal-title":"World J Surg"},{"issue":"1","key":"2183_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12028-010-9341-6","volume":"15","author":"S Taylor","year":"2011","unstructured":"Taylor S, Heinrichs RJ, Janzen JM, Ehtisham A. Levetiracetam is associated with improved cognitive outcome for patients with intracranial hemorrhage. Neurocrit Care. 2011;15(1):80\u20134.","journal-title":"Neurocrit Care"},{"issue":"12","key":"2183_CR33","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1161\/STROKEAHA.109.559948","volume":"40","author":"AM Naidech","year":"2009","unstructured":"Naidech AM, Garg RK, Liebling S, Levasseur K, Macken MP, Schuele SU, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40(12):3810\u20135.","journal-title":"Stroke"},{"issue":"1","key":"2183_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1212\/WNL.0000000000003461","volume":"88","author":"AM Naidech","year":"2017","unstructured":"Naidech AM, Beaumont J, Jahromi B, Prabhakaran S, Kho A, Holl JL. Evolving use of seizure medications after intracerebral hemorrhage: a multicenter study. Neurology. 2017;88(1):52\u20136.","journal-title":"Neurology"},{"issue":"2","key":"2183_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12028-007-0042-8","volume":"7","author":"JP Szaflarski","year":"2007","unstructured":"Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL. Levetiracetam use in critically ill patients. Neurocrit Care. 2007;7(2):140\u20137.","journal-title":"Neurocrit Care"},{"issue":"12","key":"2183_CR36","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1001\/jamaneurol.2017.2459","volume":"74","author":"AF Struck","year":"2017","unstructured":"Struck AF, Ustun B, Ruiz AR, Lee JW, LaRoche SM, Hirsch LJ, et al. Association of an electroencephalography-based risk score with seizure probability in hospitalized patients. JAMA Neurol. 2017;74(12):1419\u201324.","journal-title":"JAMA Neurol"},{"issue":"9","key":"2183_CR37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1001\/jamaneurol.2021.2249","volume":"78","author":"FJ Jones","year":"2021","unstructured":"Jones FJ, Sanches PR, Smith JR, Zafar SF, Blacker D, Hsu J, et al. Seizure prophylaxis after spontaneous intracerebral hemorrhage. JAMA Neurol. 2021;78(9):1128\u201336.","journal-title":"JAMA Neurol"},{"issue":"4","key":"2183_CR38","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamaneurol.2019.4656","volume":"77","author":"AF Struck","year":"2020","unstructured":"Struck AF, Tabaeizadeh M, Schmitt SE, Ruiz AR, Swisher CB, Subramaniam T, et al. Assessment of the validity of the 2HELPS2B score for inpatient seizure risk prediction. JAMA Neurol. 2020;77(4):500\u20137.","journal-title":"JAMA Neurol"},{"issue":"1","key":"2183_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/13696998.2021.1887877","volume":"24","author":"JP Ney","year":"2021","unstructured":"Ney JP, Gururangan K, Parvizi J. Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital setting. J Med Econ. 2021;24(1):318\u201327.","journal-title":"J Med Econ"},{"issue":"9","key":"2183_CR40","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/CCM.0000000000004428","volume":"48","author":"PM Vespa","year":"2020","unstructured":"Vespa PM, Olson DM, John S, Hobbs KS, Gururangan K, Nie K, et al. Evaluating the clinical impact of rapid response electroencephalography: the DECIDE multicenter prospective observational clinical study. Crit Care Med. 2020;48(9):1249\u201357.","journal-title":"Crit Care Med"},{"issue":"12","key":"2183_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/emermed-2020-210903","volume":"38","author":"NM Wright","year":"2021","unstructured":"Wright NM, Madill ES, Isenberg D, Gururangan K, McClellen H, Snell S, et al. Evaluating the utility of rapid response EEG in emergency care. Emerg Med J. 2021;38(12):923\u20136.","journal-title":"Emerg Med J"},{"issue":"10","key":"2183_CR42","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1212\/01.WNL.0000125184.88797.62","volume":"62","author":"J Claassen","year":"2004","unstructured":"Claassen J, Mayer SA, Kowalski RG, Emerson RG, Hirsch LJ. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology. 2004;62(10):1743\u20138.","journal-title":"Neurology"},{"issue":"1","key":"2183_CR43","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/TA.0b013e31823df31f","volume":"72","author":"FM Pieracci","year":"2012","unstructured":"Pieracci FM, Moore EE, Beauchamp K, Tebockhorst S, Barnett CC, Bensard DD, et al. A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury. J Trauma Acute Care Surg. 2012;72(1):276\u201381.","journal-title":"J Trauma Acute Care Surg"},{"issue":"8","key":"2183_CR44","doi-asserted-by":"publisher","first-page":"e751","DOI":"10.1212\/WNL.0000000000200779","volume":"99","author":"SW Terman","year":"2022","unstructured":"Terman SW, Lin CC, Kerr WT, DeLott LB, Callaghan BC, Burke JF. Changes in the use of brand name and generic medications and total prescription cost among Medicare beneficiaries with epilepsy. Neurology. 2022;99(8):e751\u201361.","journal-title":"Neurology"},{"issue":"1","key":"2183_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/CCM.0000000000006065","volume":"52","author":"E Valdes","year":"2024","unstructured":"Valdes E, Fang T, Boffa M, Frontera JA. Optimal dosing of levetiracetam for seizure prophylaxis in critically ill patients: a prospective observational study. Crit Care Med. 2024;52(1):e1-10.","journal-title":"Crit Care Med"},{"key":"2183_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.seizure.2017.07.017","volume":"51","author":"LN Zhu","year":"2017","unstructured":"Zhu LN, Chen D, Xu D, Tan G, Wang HJ, Liu L. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: an indirect comparison. Seizure. 2017;51:121\u201332.","journal-title":"Seizure"},{"issue":"6","key":"2183_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s40261-023-01272-9","volume":"43","author":"EE Leppien","year":"2023","unstructured":"Leppien EE, Doughty BJ, Hurd KL, Strong KN, Piper BJ, McCall KL. Newer antiseizure medications and suicidality: analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database. Clin Drug Investig. 2023;43(6):393\u20139.","journal-title":"Clin Drug Investig"},{"issue":"9","key":"2183_CR48","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/08850666211073598","volume":"37","author":"K Lee","year":"2022","unstructured":"Lee K, Klein P, Dongre P, Choi EJ, Rhoney DH. Intravenous brivaracetam in the management of acute seizures in the hospital setting: a scoping review. J Intensive Care Med. 2022;37(9):1133\u201345.","journal-title":"J Intensive Care Med"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-024-02183-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-024-02183-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:05:09Z","timestamp":1739444709000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-024-02183-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2183"],"URL":"https:\/\/doi.org\/10.1007\/s12028-024-02183-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5375341\/v1","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The panel was required to be free of content-related commercial conflicts of interest for participation in this committee. Disclosures unrelated to the content of this article are as follows: JAF receives grant funding for COVID-related research from the National Institutes of Health\/National Institute of Neurological Disorders and Stroke, the National Institutes of Health\/National Institute on Aging, and the National Institutes of Health\/National Heart, Lung, and Blood Institute. JAF has received consulting feeds from BrainCool, FirstKind Medical, Lumosa, and PER-Physician Education Resource. JAF has been compensated travel expenses by Alexion and receives publication royalties from Thieme. EJG receives grant funding for traumatic brain injury\u2013related research from the National Institutes of Health\/National Institute of Neurological Disorders and Stroke. EJG has received consulting fees from UCB and AAN. EJG has been compensated travel expenses by AAN. ELJ has received consulting fees from EpiWatch and receives grant funding from the National Institutes of Health\/National Institute on Aging. DO receives funding as the editor for the\n                      Journal of Neuroscience Nursing\n                      and has received research funding from the National Institutes of Health\/National Institute of Neurological Disorders and Stroke and the Agnes Marshall Walker Foundation. ET has received consulting fees from Medical Insights Group. SZ receives grant funding from the National Institutes of Health\/National Institute of Neurological Disorders and Stroke. SZ is a clinical neurophysiologist for CortiCare. AR, JSU, YY, and SR report no disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article adheres to ethical guidelines. This study did not involve human subjects and was exempt from institutional review board review according to the New York University Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}